Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changing trends

D S Rosenthal

    CA: a Cancer Journal for Clinicians
    |February 5, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Cancer statistics show a positive trend with fewer new cases and declining death rates in the US. Survival rates are improving, but disparities persist for certain demographics.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Id3 induces a caspase-3- and -9-dependent apoptosis and mediates UVB sensitization of HPV16 E6/7 immortalized human keratinocytes.

    Oncogene·2006
    Same author

    PARP determines the mode of cell death in skin fibroblasts, but not keratinocytes, exposed to sulfur mustard.

    The Journal of investigative dermatology·2002
    Same author

    PC-SPES: current evidence and remaining questions.

    CA: a cancer journal for clinicians·2001
    Same author

    Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.

    Neoplasia (New York, N.Y.)·2001
    Same author

    Role of poly(ADP-ribose) polymerase (PARP) in DNA repair in sulfur mustard-exposed normal human epidermal keratinocytes (NHEK).

    Journal of applied toxicology : JAT·2001
    Same author

    Calmodulin, poly(ADP-ribose)polymerase and p53 are targets for modulating the effects of sulfur mustard.

    Journal of applied toxicology : JAT·2001
    Same journal

    Serious mental illness and cancer: A call to action for equitable care.

    CA: a cancer journal for clinicians·2026
    Same journal

    Extranodal natural killer/T-cell lymphoma: From fatal to curable.

    CA: a cancer journal for clinicians·2026
    Same journal

    Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

    CA: a cancer journal for clinicians·2026
    Same journal

    Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

    CA: a cancer journal for clinicians·2026
    See all related articles

    Area of Science:

    • Oncology
    • Public Health
    • Epidemiology

    Background:

    • The American Cancer Society reports a significant shift in cancer statistics, marking a favorable change in direction for the first time.
    • Data indicates a reduction in the overall incidence of new cancer cases across the United States.
    • Cancer mortality rates in the US are also showing a declining trend.

    Discussion:

    • While overall survival rates for most cancers continue to improve, significant disparities remain.
    • Survival statistics highlight differences between African Americans and white populations, indicating areas needing further attention.
    • Mortality decline is more favorable among men compared to women, suggesting gender-specific factors influencing outcomes.

    Key Insights:

    • First-time favorable change in direction reported in annual cancer statistics.

    Related Experiment Videos

  • Documented reduction in new cancer cases and declining cancer death rates.
  • Continued improvement in 5-year survival rates for the majority of cancer types.

    • Outlook:

    • Addressing survival disparities between racial groups is crucial for equitable cancer care.
    • Further research is needed to understand and mitigate the gender gap in cancer mortality decline.
    • Sustained efforts in cancer prevention, early detection, and treatment are essential to maintain positive trends.